Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Post-grant proceedings at the USPTO
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Recent Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

 General Patent Litigation Firm of the Year: Fish & RichardsonPatent Impact Case of the Year: Fish & Richardson

Intellectual Property (IP) Firm of the YearIntellectual Property (IP) Practice Group of the Year

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
News
May 15, 2019
Fish & Richardson’s John B. Pegram Receives Lifetime Achievement Award from New York IPLA
Fish & Richardson’s John B. Pegram Receives Lifetime Achievement Award from New York IPLA
Press Release
Event
July 9th, 2019
One Nucleus ON Helix Conference
One Nucleus ON Helix Conference
Speaking Engagement
Sponsorship
Event
May 29th, 2019 | 8:00 am EDT
CRUSH Life Sciences Deal Meeting International
CRUSH Life Sciences Deal Meeting International
Speaking Engagement
Sponsorship
News
March 4, 2019
Fish & Richardson Principal Chad Shear Named to “Intellectual Property Trailblazers” List by The National Law Journal
Fish & Richardson Principal Chad Shear Named to “Intellectual Property Trailblazers” List by <i>The National Law Journal</i>
Press Release
News
February 4, 2019
Fish & Richardson Elevates 11 Attorneys to Principal
Fish & Richardson Elevates 11 Attorneys to Principal
Press Release
News
January 24, 2019
Fish & Richardson Attorneys Contribute Chapter to New Biosimilars Book
Fish & Richardson Attorneys Contribute Chapter to New Biosimilars Book
Press Release
News
January 16, 2019
Fish & Richardson Grows Firm With 14 Associates
Fish & Richardson Grows Firm With 14 Associates
Press Release
News
January 10, 2019
Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs
Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs
Press Release
News
January 3, 2019
Fish & Richardson Receives Two 2018 “Attorney of the Year” Awards from Minnesota Lawyer
Fish & Richardson Receives Two 2018 “Attorney of the Year” Awards from <i>Minnesota Lawyer</i>
Press Release
News
November 27, 2018
Fish & Richardson Principal Jonathan Singer Named 2018 Life Sciences MVP of the Year by Law360
Fish & Richardson Principal Jonathan Singer Named 2018 Life Sciences MVP of the Year by <i>Law360</i>
Press Release
News
October 29, 2018
Fish & Richardson Named to National Law Journal’s 2018 Appellate Hot List
Fish & Richardson Named to <i>National Law Journal</i>’s 2018 Appellate Hot List
Press Release
News
September 27, 2018
Fish & Richardson Announces 13 Principals Named 2018 “Life Sciences Stars” by LMG Life Sciences
Fish & Richardson Announces 13 Principals Named 2018  “Life Sciences Stars” by LMG Life Sciences
Press Release
load more topics